Tech Company Financing Transactions

Fundamental Applied Biology Funding Round

Fundamental Applied Biology closed a $21 million Series B funding round on 12/10/2007. Investors included Alta Partners and SV Health Investors.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

1455 Adams Drive 1015
Menlo Park, CA 94025
USA

Phone

(650) 239-9374

Website

www.cellfree.com

Email Address

[email protected]

Overview

Fundamental Applied Biology (FAB), Inc. is creating new products and opportunities in protein vaccines and therapeutics with its revolutionary platform that provides unprecedented speed and control over protein expression.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Daniel Gold

        

Chief Financial Officer

Jay Shukert

        

VP - Bus. Development

Patricia Sinatra

        

Browse more venture capital transactions:

Prev: 12/7/2007: SolarEdge Technologies venture capital transaction
Next: 12/10/2007: Asuragen venture capital transaction

Share this article

About Our VC Transactions Data

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary